These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25575569)

  • 1. Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction.
    Bonora E; Bianco F; Cordeddu L; Bamshad M; Francescatto L; Dowless D; Stanghellini V; Cogliandro RF; Lindberg G; Mungan Z; Cefle K; Ozcelik T; Palanduz S; Ozturk S; Gedikbasi A; Gori A; Pippucci T; Graziano C; Volta U; Caio G; Barbara G; D'Amato M; Seri M; Katsanis N; Romeo G; De Giorgio R
    Gastroenterology; 2015 Apr; 148(4):771-782.e11. PubMed ID: 25575569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The zebrafish mutant lessen: an experimental model for congenital enteric neuropathies.
    Uyttebroek L; Shepherd IT; Vanden Berghe P; Hubens G; Timmermans JP; Van Nassauw L
    Neurogastroenterol Motil; 2016 Mar; 28(3):345-57. PubMed ID: 26685876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Pathological Features of Severe Gut Dysmotility.
    Bianco F; Bonora E; Lattanzio G; Clavenzani P; Guarino M; Mazzoni M; Baldassarro VA; Lorenzini L; Caio G; Stanghellini V; Sternini C; Farrugia G; Giardino L; Calzà L; De Giorgio R
    Adv Exp Med Biol; 2022; 1383():9-17. PubMed ID: 36587142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction.
    Amiot A; Tchikviladzé M; Joly F; Slama A; Hatem DC; Jardel C; Messing B; Lombès A
    Gastroenterology; 2009 Jul; 137(1):101-9. PubMed ID: 19344718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel understanding on genetic mechanisms of enteric neuropathies leading to severe gut dysmotility.
    Bianco F; Lattanzio G; Lorenzini L; Diquigiovanni C; Mazzoni M; Clavenzani P; Calzà L; Giardino L; Sternini C; Bonora E; De Giorgio R
    Eur J Histochem; 2021 Nov; 65(s1):. PubMed ID: 34818877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chronic intestinal pseudo-obstruction subtype has prognostic significance in patients with severe gastrointestinal dysmotility related intestinal failure.
    Vasant DH; Kalaiselvan R; Ablett J; Bond A; Abraham A; Teubner A; Green D; Paine PA; Lal S
    Clin Nutr; 2018 Dec; 37(6 Pt A):1967-1975. PubMed ID: 30290972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls.
    Menys A; Butt S; Emmanuel A; Plumb AA; Fikree A; Knowles C; Atkinson D; Zarate N; Halligan S; Taylor SA
    Neurogastroenterol Motil; 2016 Mar; 28(3):376-83. PubMed ID: 26661570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohesin and CTCF differentially regulate spatiotemporal runx1 expression during zebrafish development.
    Marsman J; O'Neill AC; Kao BR; Rhodes JM; Meier M; Antony J; Mönnich M; Horsfield JA
    Biochim Biophys Acta; 2014 Jan; 1839(1):50-61. PubMed ID: 24321385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans.
    Le TL; Galmiche L; Levy J; Suwannarat P; Hellebrekers DM; Morarach K; Boismoreau F; Theunissen TE; Lefebvre M; Pelet A; Martinovic J; Gelot A; Guimiot F; Calleroz A; Gitiaux C; Hully M; Goulet O; Chardot C; Drunat S; Capri Y; Bole-Feysot C; Nitschké P; Whalen S; Mouthon L; Babcock HE; Hofstra R; de Coo IF; Tabet AC; Molina TJ; Keren B; Brooks A; Smeets HJ; Marklund U; Gordon CT; Lyonnet S; Amiel J; Bondurand N
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPAR1 regulates enteric nervous system function through glial signaling and contributes to chronic intestinal pseudo-obstruction.
    Ahmadzai MM; McClain JL; Dharshika C; Seguella L; Giancola F; De Giorgio R; Gulbransen BD
    J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35166239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI.
    Ohkubo H; Kessoku T; Fuyuki A; Iida H; Inamori M; Fujii T; Kawamura H; Hata Y; Manabe N; Chiba T; Kwee TC; Haruma K; Matsuhashi N; Nakajima A; Takahara T
    Am J Gastroenterol; 2013 Jul; 108(7):1130-9. PubMed ID: 23511458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of RAD21 immunoreactivity in myenteric neurons of the human and mouse small intestine.
    Bianco F; Eisenman ST; Colmenares Aguilar MG; Bonora E; Clavenzani P; Linden DR; De Giorgio R; Farrugia G; Gibbons SJ
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13429. PubMed ID: 30069982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international survey on clinicians' perspectives on the diagnosis and management of chronic intestinal pseudo-obstruction and enteric dysmotility.
    Vasant DH; Pironi L; Barbara G; Bozzetti F; Cuerda C; Joly F; Mundi M; Paine P; Staun M; Szczepanek K; Van Gossum A; Wanten G; Lal S
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13937. PubMed ID: 32696607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohesin-dependent regulation of Runx genes.
    Horsfield JA; Anagnostou SH; Hu JK; Cho KH; Geisler R; Lieschke G; Crosier KE; Crosier PS
    Development; 2007 Jul; 134(14):2639-49. PubMed ID: 17567667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic intestinal pseudo-obstruction in a child harboring a founder Hirschsprung RET mutation.
    Rossi V; Mosconi M; Nozza P; Murgia D; Mattioli G; Ceccherini I; Pini Prato A
    Am J Med Genet A; 2016 Sep; 170(9):2400-3. PubMed ID: 27273837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing.
    Dong W; Baldwin C; Choi J; Milunsky JM; Zhang J; Bilguvar K; Lifton RP; Milunsky A
    Clin Genet; 2019 Nov; 96(5):473-477. PubMed ID: 31389005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy.
    Lehtonen HJ; Sipponen T; Tojkander S; Karikoski R; Järvinen H; Laing NG; Lappalainen P; Aaltonen LA; Tuupanen S
    Gastroenterology; 2012 Dec; 143(6):1482-1491.e3. PubMed ID: 22960657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric Neuromyopathies: Highlights on Genetic Mechanisms Underlying Chronic Intestinal Pseudo-Obstruction.
    Bianco F; Lattanzio G; Lorenzini L; Mazzoni M; Clavenzani P; Calzà L; Giardino L; Sternini C; Costanzini A; Bonora E; De Giorgio R
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology, Diagnosis, and Management of Chronic Intestinal Pseudo-Obstruction.
    Downes TJ; Cheruvu MS; Karunaratne TB; De Giorgio R; Farmer AD
    J Clin Gastroenterol; 2018 Jul; 52(6):477-489. PubMed ID: 29877952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.
    Ravenscroft G; Pannell S; O'Grady G; Ong R; Ee HC; Faiz F; Marns L; Goel H; Kumarasinghe P; Sollis E; Sivadorai P; Wilson M; Magoffin A; Nightingale S; Freckmann ML; Kirk EP; Sachdev R; Lemberg DA; Delatycki MB; Kamm MA; Basnayake C; Lamont PJ; Amor DJ; Jones K; Schilperoort J; Davis MR; Laing NG
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13371. PubMed ID: 29781137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.